Geron Looks For Partnerships With Revised Leadership Team
This article was originally published in The Pink Sheet Daily
Executive Summary
Longtime CFO David Greenwood, who led the biotech's 1996 IPO, becomes president and interim CEO of Geron, whose human embryonic stem cell program is back on track.